Episode Details
Back to Episodes
FDA Approves First PCSK9 Inhibitor Pill | Johannesburg News
Description
FDA just approved Merck’s groundbreaking new cholesterol pill, Lipfendra — the first oral drug that blocks PCSK9, a protein that helps clear bad cholesterol. It’s a game-changer for patients already on statins who still need more help lowering LDL. Two major studies showed dramatic results: over 55% LDL drop in one, nearly 60% in another — with mild side effects like dizziness and diarrhea. Take it on an empty stomach, and it’s part of an expedited approval process for promising treatments. With heart disease the top killer in the U.S., this pill could be a vital new tool in the fight against heart attacks and strokes.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/12443bfbf038d759